1. Home
  2. KFFB vs ATYR Comparison

KFFB vs ATYR Comparison

Compare KFFB & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kentucky First Federal Bancorp

KFFB

Kentucky First Federal Bancorp

N/A

Current Price

$4.78

Market Cap

38.7M

Sector

Finance

ML Signal

N/A

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.46

Market Cap

46.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KFFB
ATYR
Founded
2005
2005
Country
United States
United States
Employees
N/A
58
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.7M
46.1M
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
KFFB
ATYR
Price
$4.78
$0.46
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
$3.67
AVG Volume (30 Days)
1.3K
2.1M
Earning Date
05-11-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
109.52
N/A
EPS
0.15
N/A
Revenue
$15,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$31.93
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.62
$0.40
52 Week High
$4.98
$7.29

Technical Indicators

Market Signals
Indicator
KFFB
ATYR
Relative Strength Index (RSI) 56.83 40.42
Support Level $4.20 $0.42
Resistance Level N/A $0.86
Average True Range (ATR) 0.13 0.04
MACD 0.02 0.01
Stochastic Oscillator 95.83 13.94

Price Performance

Historical Comparison
KFFB
ATYR

About KFFB Kentucky First Federal Bancorp

Kentucky First Federal Bancorp is a holding company. The company, through its subsidiaries, is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans, and types of deposits etc. The company mainly operates in Perry, Franklin, Boyle, and Garrard and surrounding counties in Kentucky, USA.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: